Based upon many positive anecdotal reports, two Scottish physicans are
in the process of funding a clinical trial of Low Dose Naltrexone (LDN)
for treating multiple sclerosis. For more information, visit

http://www.theherald.co.uk/display.var.1494742.0.0.php